Frontier Biosciences settles in China
US services provider Frontier Biosciences has announced that it has bought a majority stake in a China-based preclinical contract research organisation (CRO).
Archives for March 8, 2007
Omnicare calls Cardinal to the repackaging rescue
Omnicare has picked Cardinal Health to be its contract repackager for the drugs previously produced at its troubled Ohio facility.
AstraZeneca protects Nexium supply chain
AstraZeneca has opted for unit-level mass serialisation in a bid to protect its drug supply chain from tamperers and counterfeiting.